A multicenter dosimetry trial to evaluate radiation absorbed dose from holmium-166-DOTMP in patients with multiple myeloma
Phase of Trial: Phase I/II
Latest Information Update: 08 Apr 2009
At a glance
- Drugs Holmium-166-DOTMP; Melphalan
- Indications Multiple myeloma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 08 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Oct 2005 New trial record.